Trends in Potent Drug Contract Manufacturing
Almost fifty percent of high potency medicines are in injectable form. Semi-solid drugs come next. Due to increasing and high regulatory compliance, many companies with a few drugs in their manufacturing pipeline are searching for capable contract manufacturing organizations to fix these challenges. This blog centers on challenges that are being faced by the market with regards to the regional distribution of providers, supply, and how the increasing demand for highly potent drugs is affecting the market in terms of mergers and acquisitions, investing/upgrading in new capital, new facilities, capacity expansion, etc. Continue reading to learn more. The Challenge High potent drug contract manufacturing is one of the major revenue-generating segments in the pharmaceutical industry. There is a high demand for high-potency drugs such as IV fluids and ADCs. On the other hand, buyers are searching for high-capacity suppliers with lyophilization profic...